BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 36012647)

  • 1. Excitatory Synaptic Transmission in Ischemic Stroke: A New Outlet for Classical Neuroprotective Strategies.
    Wang F; Xie X; Xing X; Sun X
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate excitotoxicity: Potential therapeutic target for ischemic stroke.
    Shen Z; Xiang M; Chen C; Ding F; Wang Y; Shang C; Xin L; Zhang Y; Cui X
    Biomed Pharmacother; 2022 Jul; 151():113125. PubMed ID: 35609367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excitatory and inhibitory amino acid neurotransmitters in stroke: from neurotoxicity to ischemic tolerance.
    Amantea D; Bagetta G
    Curr Opin Pharmacol; 2017 Aug; 35():111-119. PubMed ID: 28826602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is pharmacological neuroprotection dependent on reduced glutamate release?
    Calabresi P; Picconi B; Saulle E; Centonze D; Hainsworth AH; Bernardi G
    Stroke; 2000 Mar; 31(3):766-72; discussion 773. PubMed ID: 10700517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies.
    Calabresi P; Centonze D; Cupini LM; Costa C; Pisani F; Bernardi G
    Neurobiol Dis; 2003 Feb; 12(1):82-8. PubMed ID: 12609492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excitotoxicity and stroke: identifying novel targets for neuroprotection.
    Lai TW; Zhang S; Wang YT
    Prog Neurobiol; 2014 Apr; 115():157-88. PubMed ID: 24361499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mechanism of neuroprotection: Blood glutamate grabber.
    Castillo J; Loza MI; Mirelman D; Brea J; Blanco M; Sobrino T; Campos F
    J Cereb Blood Flow Metab; 2016 Feb; 36(2):292-301. PubMed ID: 26661174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targets of cytoprotection in acute ischemic stroke: present and future.
    Lizasoain I; Cárdenas A; Hurtado O; Romera C; Mallolas J; Lorenzo P; Castillo J; Moro MA
    Cerebrovasc Dis; 2006; 21 Suppl 2():1-8. PubMed ID: 16651809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of ischemia and glutamate excitotoxicity.
    Neves D; Salazar IL; Almeida RD; Silva RM
    Life Sci; 2023 Sep; 328():121814. PubMed ID: 37236602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4,5 caffeoylquinic acid and scutellarin, identified by integrated metabolomics and proteomics approach as the active ingredients of Dengzhan Shengmai, act against chronic cerebral hypoperfusion by regulating glutamatergic and GABAergic synapses.
    Sheng N; Zheng H; Li M; Li M; Wang Z; Peng Y; Yu H; Zhang J
    Pharmacol Res; 2020 Feb; 152():104636. PubMed ID: 31926275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective Strategies for Ischemic Stroke-Future Perspectives.
    Haupt M; Gerner ST; Bähr M; Doeppner TR
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotransmitters in the mediation of cerebral ischemic injury.
    Mayor D; Tymianski M
    Neuropharmacology; 2018 May; 134(Pt B):178-188. PubMed ID: 29203179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disrupted Ionic Homeostasis in Ischemic Stroke and New Therapeutic Targets.
    Hu HJ; Song M
    J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2706-2719. PubMed ID: 29054733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multiomics and network pharmacological study reveals the neuroprotective efficacy of Fu-Fang-Dan-Zhi tablets against glutamate-induced oxidative cell death.
    Gu Y; Huang P; Cheng T; Yang J; Wu G; Sun Y; Liu A; Li H; Zhao J; Ye J
    Comput Biol Med; 2022 Sep; 148():105873. PubMed ID: 35868043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies.
    Paul S; Candelario-Jalil E
    Exp Neurol; 2021 Jan; 335():113518. PubMed ID: 33144066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synaptic and extrasynaptic glutamate signaling in ischemic stroke.
    Chao N; Li ST
    Curr Med Chem; 2014; 21(18):2043-64. PubMed ID: 24372211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic stroke: "acidotoxicity" is a perpetrator.
    Huang Y; McNamara JO
    Cell; 2004 Sep; 118(6):665-6. PubMed ID: 15369664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of N-acetyl-aspartyl-glutamate on synaptic and extrasynaptic NMDA receptors are subunit- and pH-dependent in the CA1 region of the mouse hippocampus.
    Khacho P; Wang B; Ahlskog N; Hristova E; Bergeron R
    Neurobiol Dis; 2015 Oct; 82():580-592. PubMed ID: 26303888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacology of neuroprotection in acute ischemic stroke].
    Fernández-Gómez FJ; Hernández F; Argandoña L; Galindo MF; Segura T; Jordán J
    Rev Neurol; 2008 Sep 1-15; 47(5):253-60. PubMed ID: 18780272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications.
    Tuo QZ; Zhang ST; Lei P
    Med Res Rev; 2022 Jan; 42(1):259-305. PubMed ID: 33957000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.